Back
Avalo Therapeutics Stock Predictions
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
7
AVTX
Avalo Therapeutics
Last Price:
$5.75
Seasonality Move:
28.47%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Avalo Therapeutics Stock Forecast
-
Over the next 52 weeks, Avalo Therapeutics has on average historically risen by 26% based on the past 9 years of stock performance.
-
Avalo Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is Avalo Therapeutics Stock Undervalued?The current Avalo Therapeutics [AVTX] share price is $5.80. The Score for AVTX is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
-
AVTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Avalo Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Avalo Therapeutics has on average historically risen by 26% based on the past 9 years of stock performance.
Avalo Therapeutics Stock Rating
Sell
7
Avalo Therapeutics (AVTX)
is a Sell
Is Avalo Therapeutics overpriced?
-
Avalo Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Avalo Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
avalotx.com
52-Week Data
52-Week High:
18.79
52-Week Low:
5.56
Prediction Charts
Market Cap:
61.9M
Price in USD:
5.80
Volume:
51.2K
Beta:
1.20
Technical Analysis
SMA50:
7.59
SMA100:
8.57
SMA200:
9.68
52-Wk Change:
-64.42%
Stock Predictions
-
Is Avalo Therapeutics stock public?Yes, Avalo Therapeutics is a publicly traded company.
-
What is the Avalo Therapeutics stock quote today?The Avalo Therapeutics stock price is 5.80 USD today.
-
How to buy Avalo Therapeutics stock online?You can buy Avalo Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-18 | 7.70 | 7.77 | 7.88 | 7.28 |
| Mar-19 | 7.60 | 7.99 | 8.00 | 7.60 |
| Mar-20 | 7.65 | 8.22 | 8.30 | 7.65 |
| Mar-21 | 7.90 | 7.66 | 8.19 | 7.47 |
| Mar-24 | 7.60 | 7.63 | 7.63 | 6.98 |
| Mar-25 | 8.47 | 8.54 | 9.70 | 8.14 |
| Mar-26 | 8.90 | 8.36 | 8.99 | 8.04 |
| Mar-27 | 8.40 | 8.73 | 9.00 | 7.88 |
| Mar-28 | 8.57 | 8.46 | 8.90 | 8.16 |
| Mar-31 | 8.17 | 8.01 | 8.46 | 7.72 |
| Apr-1 | 8.37 | 6.85 | 8.37 | 6.81 |
| Apr-2 | 6.98 | 7.08 | 7.41 | 6.98 |
| Apr-3 | 6.90 | 6.59 | 7.00 | 6.40 |
| Apr-4 | 6.52 | 5.80 | 6.52 | 5.56 |
Avalo Therapeutics Earnings
Avalo Therapeutics Earnings Report: Per Share Avalo Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Avalo Therapeutics Forecast Revenue Growth
Avalo Therapeutics Stock Analysis: Historical quarterly revenues per share for Avalo Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $3.33 per share, a decrease next quarter of $0.46 per share, a decrease this year of $18.12 per share, and an increase next year of $1.00 per share.
* Avalo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.